{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:09:36Z","timestamp":1785460176029,"version":"3.56.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Model-based economic evaluations rely on results of diagnostic test accuracy (DTA) studies to assess the value-for-money of a new diagnostic or prognostic test. The 30-item Standards for Reporting of Diagnostic Accuracy Studies (STARD) 2015 guidelines are the gold-standard guidelines for DTA studies. In this Perspective paper, we conducted a rapid review of publicly available economic evaluations of a new diagnostic test between 2012 and 2025 to formulate eight elements that we believe could be added to STARD 2015 to help enhance the credibility of DTA-based economic evaluations. Examples from the rapid review and practical recommendations were provided.<\/jats:p>","DOI":"10.3389\/fpubh.2025.1729822","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:59:48Z","timestamp":1767769188000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Addressing the need for economic modelling when designing and reporting a diagnostic testing accuracy study"],"prefix":"10.3389","volume":"13","author":[{"given":"Xuanqian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessalyn K.","family":"Holodinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"ref1","year":"2017"},{"key":"ref2","first-page":"h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume-title":"BMJ","author":"Bossuyt","year":""},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19820","article-title":"Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath","volume":"19","author":"Harnan","year":"2015","journal-title":"Health Technol Assess"},{"key":"ref4","first-page":"1","article-title":"Interferon-gamma release assay testing for latent tuberculosis infection: a health technology assessment","volume":"24","year":"2024","journal-title":"Ont Health Technol Assess Ser"},{"key":"ref5","article-title":"Appendix M. Cost effectiveness analysis in diagnosis of asthma in adults and young people aged over 16","volume-title":"Asthma: diagnosis and monitoring of asthma in adults, children and young people (NICE guideline NG80)","year":"2017"},{"key":"ref6","first-page":"58","volume-title":"The clinical effectiveness and cost of a pneumococcal urine antigen immunochromatographic test (BinaxNOW","author":"Sinclair","year":"2012"},{"key":"ref7","first-page":"1","article-title":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a health technology assessment","volume":"19","year":"2019","journal-title":"Ont Health Technol Assess Ser"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3390\/cancers14071729","article-title":"Cost-effectiveness of artificial intelligence support in computed tomography-based lung Cancer screening","volume":"14","author":"Ziegelmayer","year":"2022","journal-title":"Cancer"},{"key":"ref9","first-page":"1","article-title":"DNA methylation\u2013based classification for central nervous system tumours: a health technology assessment","volume":"25","year":"2025","journal-title":"Ont Health Technol Assess Ser"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1128\/JCM.00137-13","article-title":"Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae","volume":"51","author":"Sinclair","year":"2013","journal-title":"J Clin Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/0272989X221089268","article-title":"Developing economic models for assessing the cost-effectiveness of multiple diagnostic tests: methods and applications","volume":"42","author":"Xie","year":"2022","journal-title":"Med Decis Mak"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/bmj.332.7549.1089","article-title":"Comparative accuracy: assessing new tests against existing diagnostic pathways","volume":"332","author":"Bossuyt","year":"2006","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/sim.7148","article-title":"Understanding the effects of conditional dependence in research studies involving imperfect diagnostic tests","volume":"36","author":"Wang","year":"2017","journal-title":"Stat Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jrsm.1243","article-title":"Evaluating the accuracy and economic value of a new test in the absence of a perfect reference test","volume":"8","author":"Xie","year":"2017","journal-title":"Res Synth Methods"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"j5779","DOI":"10.1136\/bmj.j5779","article-title":"Concerns about composite reference standards in diagnostic research","author":"Dendukuri","year":"2018","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jval.2019.08.008","article-title":"Quebec health-related quality-of-life population norms using the EQ-5D-5L: decomposition by sociodemographic data and health problems","volume":"23","author":"Poder","year":"2020","journal-title":"Value Health"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10198-023-01570-1","article-title":"Canada population norms for the EQ-5D-5L","volume":"25","author":"Yan","year":"2024","journal-title":"Eur J Health Econ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/jhmhp-20-47","article-title":"Challenges in health technology assessments of genetic tests","volume":"4","author":"Xie","year":"2020","journal-title":"J Hosp Manag Health Policy"},{"key":"ref19","first-page":"2506.17442","article-title":"Keeping medical AI healthy: a review of detection and correction methods for system degradation","volume-title":"arXiv [Preprint]","author":"Guan","year":"2025"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1038\/s41598-022-15245-z","article-title":"Temporal quality degradation in AI models","volume":"12","author":"Vela","year":"2022","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e000891","DOI":"10.1136\/bmjonc-2025-000891","article-title":"Five years after CONSORT-AI, not much has changed: a call to action for artificial intelligence research in oncology","volume":"4","author":"Kwong","year":"2025","journal-title":"BMJ Oncol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-019-0447-x","article-title":"End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography","volume":"25","author":"Ardila","year":"2019","journal-title":"Nat Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e48633","DOI":"10.2196\/48633","article-title":"Barriers to and facilitators of artificial intelligence adoption in health care: scoping review","volume":"11","author":"Hassan","year":"2024","journal-title":"JMIR Hum Factors"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"100231","DOI":"10.1016\/j.mcpdig.2025.100231","article-title":"United States Food and Drug Administration regulation of clinical software in the era of artificial intelligence and machine learning","volume":"3","author":"Singh","year":"2025","journal-title":"Mayo Clinic Proc. Digital Health"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1729822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:59:51Z","timestamp":1767769191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1729822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":24,"alternative-id":["10.3389\/fpubh.2025.1729822"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1729822","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1729822"}}